Efficacy of AccuVein V400 to Facilitate Peripheral Intravenous Placement in Sickle Cell Disease Adults With Vaso-occlusive Crisis : a Randomized Clinical Trial

Study point of contact

Ranque Brigitte, MD, PhD
0033 1 56093331
[email protected]
Jean-Benoit Arlet, MD,PhD
0033 1 56093331
[email protected]

Locations

2 France sites

Age

> 18 Years

Phase

N/A

Study type

Interventional

Gender

All

Interventions

Device

Other

Compensation

Unknown

About the study

The primary goal of this randomized, controlled, open-label study is to determine the
efficacy of AccuveinV400 (a transillumination veins device) to facilitate peripheral
intravenous (IVP) catheter placement during a vaso-oclusive crisis. The investigators
hypothesized that the number of attempts to a successful placement of a peripheral IV, our
primary outcome, would be shorter with the assistance of the Accuvein V400. It is also
expected that AccuveinV400 will reduce the time of the procedure, the rate of failure, the
technique-related pain.

participation requirements

– Sickle cell patients (all genotypes)

– Patients hospitalized for uncomplicated vaso-occlusive crisis (CVO) in
Internal/general Medicine department

– Patients requiring the placement or replacement of a peripheral intra-venous catheter
in the Department of Internal/general Medicine

– Patients arrived in the internal/general medicine department of the hospital between
9h and 18h and except weekends

– Signed informed consent.

– Affiliated to the French health care insurance.

participation restrictions

– Signs of shock

– Acute chest Syndrome

– Central venous catheter already present

– Indication to have a central venous catheter from the ourset

– Patient who has already participated to the PERFID study during the current
hospitalization

– Refusal of the patient’s participation

– Pregnant or lactating woman

– Patient under guardianship or curatorship

Locations

  • Paris, Ile-de-France, France, AP-HP - Hopital Europeen Georges-Pompidou Paris, France, 75908 [Recruiting]
  • Créteil, France, CHU H. Mondor [Not yet recruiting]